A study to determine patient specific and general beliefs towards medication and their treatment compliance to selected systemic therapies in chronic inflammatory diseases (ALIGN)

Not Applicable

Recruiting

• Conditions: Rheumatoid Arthritis; Psoriasis; Psoriatic Arthritis; Ankylosing spondylitis; Crohn's disease; Ulcerative Colitis; Inflammatory bowel disease.; Inflammatory and Immune System - Other inflammatory or immune system disorders; Inflammatory and Immune System - Rheumatoid arthritis; Oral and Gastrointestinal - Inflammatory bowel disease

• Registration Number: ACTRN12612000977875
• Lead Sponsor: AbbVie Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-09-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 330

Inclusion Criteria

Female/male
18 years or over
Patients with Immune Mediated Inflammatory Disorders as diagnosed by a rheumatologist, gastroenterologist or dermatologist.
On current treatment with systemic either conventional and/or biologic immuno-modulating and/or disease-modifying drugs.

Exclusion Criteria

Not applicable

Study & Design

• Study Type: Observational
• Study Design: Not specified